| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
Classified under Biotechnology (Health Care sector), BMRN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $12.03M | - | |
| CFO | 123.3K | $6.91M | - | |
| VP | 84.1K | $4.72M | - | |
| VP | 61.0K | $4.04M | - | |
| Dir | 49.4K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2022 | Alles Mark J | Director | Buy | 3,625 | $86.75 | $314,468.75 | +49.8% | +32.4% | -6.0% | |
| Oct 14, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sell | 4,000 | $89.89 | $359,560.00 | -1.2% | +30.2% | -1.0% | |
| Aug 15, 2022 | Bienaime Jean Jacques68 | Chief Executive Officer | Sell | 7,000 | $94.95 | $664,630.00 | -2.1% | -12.9% | -6.5% | |
| Aug 11, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 3,000 | $95.62 | $286,860.00 | -6.4% | -14.9% | -6.0% | |
| Aug 9, 2022 | Davis George Eric65 | EVP, Chief Legal Officer | Sale+OE | 51,216 | $95.96 | $4,914,663.78 | -48.1% | -15.0% | -2.6% | |
| Aug 8, 2022 | Guyer Charles Greg70 | EVP, Chief Technical Officer | Sell | 6,205 | $96.56 | $599,154.80 | -12.8% | -15.0% | -5.3% | |
| Aug 5, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 3,500 | $94.50 | $330,750.00 | -10.2% | -11.4% | -7.6% | |
| Jul 8, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sell | 7,337 | $89.50 | $656,661.50 | -19.3% | +2.8% | -4.4% | |
| Jul 8, 2022 | Davis George Eric65 | EVP, Chief Legal Officer | Sell | 7,398 | $90.00 | $665,820.00 | -11.2% | +2.8% | -4.4% | |
| May 26, 2022 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sell | 1,308 | $78.94 | $103,253.52 | -2.4% | +17.8% | +12.2% |